Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 11, 2026

Surgeon almost goes broke on a $665K salary thanks to 1 sneaky financial fee. Ramit Sethi sets things straight

View original at finance.yahoo.com
Surgeon almost goes broke on a $665K salary thanks to 1 sneaky financial fee. Ramit Sethi sets things straight Ramit Sethi / Youtube Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Forecasting 9% price returns from 2024 to 2034

    80% confidence
  • Would happily pay a financial advisor for fixed-fee services like asset allocation review

    80% confidence
  • One asset will surge 400% in a year

    80% confidence
  • Jeff and Susan's 1.24% AUM fee would cost them $863,170 over 35 years on their $460,000 portfolio

    80% confidence
  • If you feel bad about money at $50,000, you're probably going to feel that way when you make 10 times your income

    80% confidence
  • Some advisory fees can be negotiable

    80% confidence
  • Most advisors make their money when portfolio grows, which is why they love older people and wealthy people who don't understand commission structures

    80% confidence
  • You want to pay a flat fee, never a percentage

    80% confidence
  • Generally feels most people are good and not trying to rip them off

    80% confidence
  • Would never pay a percentage of assets under management

    80% confidence
  • Projecting around 5.5% returns for 2024-2034 period

    80% confidence
  • Financial advisor told her fee was roughly around 1% and downplayed its significance

    80% confidence
  • Nearly 50% of Americans are making 1 big Social Security mistake

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Surgeon almost goes broke on a $665K salary thanks to 1 sneaky financial fee. Ramit Sethi sets things straight — Source | Via News | ViaNews Market